Find the Perfect Plan for Your Investment Journey
V
Latest price
52 Week Range
€0.62 - €6.30
Next Earnings Date
Apr 29 2025
Next Earnings Date
Apr 29 2025
Latest price
Market Cap | €47.18M |
EV | €31.92M |
Shares Outstanding | 26.07M |
Beta | 1.97 |
Analyst Rating | HOLD |
Analyst Target Price | €5.50 |
P/E 2024E | - |
P/Revenue 2024E | - |
Revenue | - |
EPS | -10.50% |
Operating Cash Flow | -15.40% |
Free Cash Flow | -8.70% |
Revenue | - |
EPS | 11.70% |
Operating Cash Flow | 3.30% |
Free Cash Flow | -21.00% |
Gross Margin 2024E | - |
Net Profit Margin 2024E | - |
ROE 2024E | -161.30% |
ROCE 2023 | -107.38% |
DPS 2024E | €0.00 |
Payout Ratio 2024E | 0.00% |
Div. Yield 2024E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
V
Vivoryon Therapeutics N.V.
VVY
Sector
Healthcare
Industry
Biotechnology
CEO
Weber, Frank
Employees
15
Website
www.vivoryon.comIPO Date
2014-10-27
Headquarters
Weinbergweg 22, Halle, Saxony-Anhalt, 06120, Germany
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved